Bluejay Therapeutics
0 followers
About Bluejay Therapeutics
Bluejay Therapeutics is a private biopharmaceutical company that specializes in developing curative treatments for viral infections and liver diseases, including CHB and CHD.
Recent News
Mirum Pharmaceuticals to Acquire Bluejay Therapeutics, for Up To $820M
Fed Rate Cut Tailwind, Lilly’s Triple Agonist Delivers Big, Vaccine Policy Turmoil — This Week in Biotech #81
Mirum Acquires Bluejay, Adding Brelovitug Treatment for HDV
Mirum Pharmaceuticals Reports P-IIb (VISTAS) Trial Data on Volixibat in Primary Sclerosing Cholangitis (PSC) Patients with Cholestatic Pruritus